Its quarter numbers were horrible. Should be more pressure now. Think management is clueless to what's going on.
-
General DiscussionCP Bulletin Important: Board Posting Policies Ask the Webmaster CP Group Discussion The Darkened Sample Closet Latest CP Job Ratings Ask a Whistleblower Attorney Employment Harassment & Discrimination Forum Healthcare Reform Discussions Cafepharma Playground In the Pipe MyPharma Sports Talk Fitness and Nutrition Political Discussions The Politics of Healthcare Financial Forum How do I... Tricks of the Trade Industry Veterans Industry Veterans - registered posting only
Tell Me About Your Company Industry Rumors Hidden Jobs Job-Seekers Dealing with Your Manager MSL Board -
Pharma/BiotechPharma/Biotech Comp - Gen Discussion |Pharma Sales Pharma and COVID-19 Pharma/Biotech Companies - Virtual/Inside Sales AI in Pharma/Biotech Pharma/Biotech Companies - Job Openings Pharma/Biotech Companies - Compliance Pharma/Biotech Companies - Managed Care and Reimbu Pharma/Biotech Companies - In the News Pharma/Biotech Companies - Stock Discussions Biotech Startups Abbott Abbott Nutrition AbbVie Latest AbbVie news
Acadia Pharmaceuticals Acorda Therapeutics Acrotech Biopharma Actelion ADMA Biologics AEterna Zentaris Agios Pharmaceuticals Aimmune Akebia Alcami Alcon Alcresta Alexion Alimera Sciences Alkermes Allegis Pharmaceuticals Allergan Alnylam Pharmaceuticals Amarin Amgen Amplity Amylx Apellis Apotex Aqua Pharmaceuticals Archimedes Pharma Arcutis Ardelyx Argenx ARS Pharma Arvinas Ascend Therapeutics Ascendis Ashfield Healthcare Astellas AstraZeneca AstraZeneca news
Atley Pharmaceuticals Autolus Therapeutics Avidas Pharmaceuticals AVEO Oncology Avion Pharmaceuticals Axsome Therapeutics AYTU BioPharma Azurity Pharmaceuticals Basilea Bausch & Lomb Baxter Bayer Biocodex Biocon Biologics Biofrontera Biogen Biohaven Boehringer Ingelheim Braeburn Pharmaceuticals Braintree Laboratories Bristol-Myers Squibb Cadence Pharmaceuticals Camber Pharmaceuticals Camurus Cangene BioPharma Caswood Catalyst Pharmaceuticals Celgene Cell Therapeutics Celltrion USA Centocor Ortho Biotech Centrix Pharmaceuticals Cephalon Chelsea Therapeutics Chiesi USA Chiron Circassia Pharmaceuticals Clarus Therapeutics Clinical Data Clovis Oncology Coherus BioSciences CollaGenex Collegium Pharmaceutical Columbia Labs Commonwealth Pharma Compass Therapeutics Cord Blood Registries Corium Covidien Crinetics Pharmaceuticals Critical Therapeutics CSL Behring Cubist Cumberland Pharmaceuticals Currax Pharmaceuticals CV Therapeutics Cycle Pharmaceuticals Cypress Bioscience Daiichi-Sankyo DARA BioSciences Dendreon Depomed Dermavant Dermik Laboratories Dermira Dey Discovery Labs Durata Therapeutics Dynavax ECR Pharmaceuticals Edwards Pharmaceuticals Egalet Eisai EKR Therapeutics Elan Eli Lilly Latest Lilly News
Emergent Biosolutions Endo Enzon Esperion EUSA Pharma Exaeris Exelixis Exeltis Eyetech Pharmaceuticals Ferndale Labs Ferring Forest Laboratories FSC Pediatrics Galderma Genentech Gensco Laboratories Genta Genzyme Gilead Sciences Gilead Sciences news
GlaxoSmithKline Graceway Greenwich Biosciences Greer Grifols USA GTX Halozyme Therapeutics Hawthorn Pharmaceuticals HCP Concierge Heron Therapeutics Horizon Pharma Hospira Human Genome Sciences ImClone IM HealthScience Immunocore Impax Labs/Global Incline Therapeutics Incyte Indivior Innovex Insmed Insys Therapeutics Intarcia Therapeutics Intercept Pharma InterMune Intrabio Intra-Cellular Therapies Inventiva Ionis Pharmaceuticals Ipsen IQVIA Sales Iroko Ironshore Pharmaceuticals Ironwood Pharmaceuticals Ista Pharma Janssen Jazz Pharmaceuticals JDS Pharmaceuticals Johnson & Johnson latest J&J news
Jounce Therapeutics Journey Medical Corp Kadmon Pharmaceuticals Kala Pharmaceuticals Kaleo Pharma Kedrion Kenuve Keryx Biopharmaceuticals Kite Pharma Kowa Pharmaceuticals Kyowa Kirin Lannett Leo Pharmaceuticals Lexicon Pharmaceuticals Ligand L'Oreal Dermatology Luitpold Pharmaceuticals Lundbeck Lupin Madrigal Pharmaceuticals MannKind Mallinckrodt Marinus Mayne Pharma MCR American Pharmaceuticals Mead Johnson Nutritionals Meda Medicines360 Medicis MedImmune Medivation Medix Melinta Therapeutics Merck Merrimack Pharma Merz Pharmaceuticals Metagenics Middlebrook Pharmaceuticals Millennium/Takeda Oncology Company Mission Pharmacal Mitsubishi Tanabe Pharma Moderna Therapeutics Morphosys Myriad Pharmaceuticals Nephron Pharmaceuticals Nestle Health Science Nestle Pediatric Nutrition Neurelis Neurocrine NeurogesX New Haven Pharmaceuticals NexMed Nitromed Novaquest Novartis Novavax Noven Pharmaceuticals Novo Nordisk NPS Pharmaceuticals Nuerex Pharmaceuticals Numedica Nycomed Octapharma Odyssey On Call ONY Inc. Onyx Pharmaceuticals Optimer Pharmaceuticals Optinose Orapharma Orexigen Therapeutics Orexo Organon Ortho Biotech Oscient Pharmaceuticals Osiris Otonomy Otsuka Oyster Point Pharma Pacira Pan American Laboratories PamLabs LLC Par Paratek Par Sterile Products PDI Dedicated PDI Shared PDL Biopharma Peregrine Pharmaceuticals Pernix Perrigo Pharmaceuticals Pfizer Latest Pfizer news
Pfizer Consumer Healthcare Pharmacyclics Phathom Pharmaceuticals Pinnacle Biologics Poly Pharmaceuticals Procter & Gamble Prometheus Labs Promius Pharma ProPharma Sales PruGen Puma Biotechnology Purdue Questcor Radius Health Ranbaxy Reckitt Benckiser Regeneron Relypsa Revance Biotech Rion Health Ritedose Roche Romark RVL Pharmaceuticals Sage Therapeutics SagePath Medical Salix Sandoz Sanofi Santarus Savient Scilex Pharmaceuticals Seattle Genetics Sebela Pharmaceuticals Seqirus Serono Servier Shionogi Shire Sirion Therapeutics SkinMedica Slate Pharma Sobi Solstice Neurosciences Solvay Somaxon Spectrum Pharmaceuticals Sprout Pharmaceuticals Stiefel Labs Strongbridge Biopharma Stratus Pharmaceuticals Sucampo Summit Therapeutics Sun Pharma Sunesis Pharmaceuticals Sunovion Supernus Syneos Health Synthon Taiho Oncology Takeda Talecris Biotherapeutics Taro Pharmaceuticals Tarsus Pharmaceuticals TEAMM Pharmaceuticals Telesta Therapeutics Telix Pharmaceuticals Tesaro Teva Neuroscience Teva Oncology Teva Respiratory Teva Women's Health Thea Pharma TherapeuticsMD TherRx Thrombogenics Titan Pharmaceuticals Travere Therapeutics Tris Pharma UCB Pharma Ultragenyx United Therapeutics Upsher Smith Labs US WorldMeds Valeant Pharmaceuticals Valera Pharmaceuticals Vanda Pharmaceuticals Vanguard Pharma VaxInnate Veloxis Pharmaceuticals Vericel Vertex Vertical Pharmaceuticals Veru Pharma Verus Pharmaceuticals VI Aesthetics Viatris ViroPharma Vivus Pharmaceuticals Warner Chilcott Watson Wraser Pharmaceuticals Xanodyne Xenoport Pharmaceuticals Xeris Pharma Xymogen Zealand Pharma Zogenix ZS Pharma Zylera Pharma Zymogenetics -
Lab/DiagnosticsLaboratory/Diagnostic Sales General Discussion Lab/Diagnostics and COVID-19 Laboratory/Diagnostic Sales - Managed Care and Rei Acupath Labs Accurate Diagnostic Labs Aegis Sciences Corporation Akers Biosciences AIT Laboratories Alliance Imaging American Pathology Partners Ameripath Ameritox Ammon Labs Aperio Ariosa ASPiRA Labs Atherotech Aureon Labs Aurora Diagnostics AVEE BillionToOne Bio Reference Blood Centers of Wisconsin Blue Earth Diagnostics Bostwick Laboratories Calloway Laboratories Caris Life Sciences Castle Medical Labs CBL Clarient Cordant Health Solutions CPL CSI Laboratories Cylex Cytyc Dermpath Diagnostic Imaging Companies Digene Dominion Diagnostics Empire City Labs Enzo Laboratories Eurofins Exact Sciences Exosome Diagnostics Fellow Foundation Medicine Genomic Health Genoptix Genova Diagnostics GI Path Guardant Health Hunter Labs Insight Health Interpace Diagnostics Interpath Laboratory Invitae Know Error Labcorp LabSource Leica Liposcience Lucid Diagnostics Manhattan Labs MedComp Sciences Medical Diagnostic Laboratories (MDL) Millennium Laboratories MobilexUSA Miraca Life Sciences Myriad Genetics NanoString NantWorks Natera Neogenomics Omnyx Oncoplex Diagnostics OPKO Health OPKO Renal Ovagene Oncology Oxford Immunotec PAML/Paclab PathGroup Pathline Labs Pathnostics Pathway Genomics Phenogen Sciences Philips Pathology Phosphorus Diagnostics Physicians Choice Laboratory Services Plus Diagnostics Polymedco Predictive Biosciences Precision Therapeutics Progenity Proove Biosciences QDx Pathology Quest Diagnostics Quidel Renaissance Rx Sequenom Shiel Solstas Lab Partners SOPHiA Genetics StrataDX Summit Diagnostics Synergy Laboratories Theranos Labs Thermo Fisher Scientific Tri-path True Health Diagnostics United Allergy Services Ventana Medical Systems Veractye VWR International
-
Animal HealthAbbott Animal Health Antech Diagnostics Arthrex Vet Systems Bayer Animal Health Boehringer Ingelheim Vetmedica Butler CEVA Columbus Serum Covetrus DVM Resources Elanco Idexx labs Intervet Merial Midwest MWI Novartis Animal Health Parnell Veterinary Pharmaceuticals Patterson Veterinary Pegasus Laboratories Penn Vet Pfizer Animal Health Schering Plough Animal Health Veterinary Imaging Companies Veterinary Rx Diets Virbac Zoetis
-
Medical Equipment/DeviceMedical Equipment/Device Sales-General Discussion Med Device and COVID-19 Medical Equipment/Device Sales - Compliance Medical Equipment/Device Sales - Credentialing Medical Equipment/Device Sales - In the News Medical Equipment/Device - Stock Discussions AADCO Medical Abbott Device Abbott Vascular Abiomed Acclarent ACell Acumed Aerocrine All Star Oxygen Alvimedica Ambu American Medical Systems AngioDynamics Applied Medical Apria Apyx Medical Aragon Surgical Arjohuntleigh Arthrex Arthrotek Orthopedics Ascensia Diabetes Care Atrium Medical Augusta Medical Systems Avinger Axogen Becton Dickinson Biomet Orthopedics Biotronik Bioventus Blue Belt Technologies Boston Scientific Bracco Diagnostics Brainlab BSN Medical B. Braun Medical Caldera Medical Canfield Imaging Systems Cardionet Cardiovascular Systems Cardiva Medical CareFusion Coapt Systems Coloplast Conceptus ConforMIS Conmed Contract Manufacturer Reps ConvaTec Cook Cooper Surgical Corza Medical Covidien CR Bard CryoLife CSI Cutera Cyberonics Cytyc Surgical Products Daniels Sharpsmart Depuy Mitek DePuy Ortho DeRoyal Dexcom DJ Orthopedics Dornier Dynasplint Edwards Life Sciences Encision EndoChoice Endogastric Solutions Entellus Medical ERMI Ethicon Device Exactech Orthopedics Fidia Fresenius Medical Gambro GE Healthcare General Medical Sales [moved to new board at top o Genzyme Globus Medical GN ReSound Gore Medical Greiner Bio-One Gyrus Guided Therapeutics Haemonetics Halyard Health Hanger Healthtronics Healthpoint Medical Hill-Rom Histogenics Hollister Hologic Idev Technologies IMRIS Inari Medical Independent Medical Contractors Integra Life Sciences Intuitive Surgical Intuitive Surgical Patient Discussions
iRhythm Karl Storz KCI Kimberly-Clark KLS Martin Laborie LDR Medical LeMaitre Vascular LifeCell Lifewatch Lincare Linvatec Magnolia Medical Technologies MAKO Surgical Mammotome Maquet Medical Systems Masimo Mazor Robotics McGhan Medacta Medartis Medela Mederi Therapeutics The Medicines Company Medafor Medline Medtronic Mentor Mercury Medical Merit Medical Microline Surgical/Starion Instruments MicroPort Orthopedics Mimedx Mimic Technologies Mindray Minerva Surgical Molnlycke Mpathy Medical Natus Medical Neomend Neotract NeuroMetrix Neurotron Neurowave Medical Technologies Nevro Nexus Spine Norgenix Novadaq Novasys Medical NuVasive Oceana Therapeutics Olympus Olympus Endoscopy Organogenesis Orthofix OsteoMed Oticon Otto Bock Owens & Minor Pacific Pulmonary Services Paragon 28 Penumbra Philips Healthcare Phonak Plus Orthopedics PolyNovo Preferred Homecare Procept BioRobotics Q-Med Regenesis Biomedical Richard Wolf Medical Rotech RS Medical Salient Surgical SCA Americas Sciton Sensus Healthcare Siemens Healthcare Sicel Technologies Sivantos Small Bone Innovations Smith & Nephew Smiths Medical Solta Medical Solventum Sonosite Sorin Spiracur Stamen Medical Systems Starkey Hearing Technologies Starplex Scientific St Jude Medical Stryker SuperCare Surgiquest Synthes Systagenix Wound Care TARIS Biomedical TEI Biosciences Teleflex Medical Terumo Medical Corporation Thornhill Research Tornier TransEnterix Treace Medical Tri-anim Ulthera ULURU, Inc. Universal Hospital Services Uromedica Uroplasty US Endoscopy Vascular Solutions Vein Clinics of America Verathon Verichip Vision Sciences Vital Signs VNUS Technologies Vyaire Welch Allyn Widex Wright Medical Zeltiq Zimmer Zoll Medical
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an alternative browser.
You should upgrade or use an alternative browser.
Its quarter numbers were horrible. Should be more pressure now. Think management is clueless to what's going on.
anonymous
Guest
anonymous
Guest
Team Esperion-thanks for your diligence the past little while as we navigate through a difficult period. I'm extremely pleased with the effort the team has put forth. Yes, clinics are closed for the time being. But, they will reopen. I hear of the discussion about me and the company on CP. I don't routinely follow as often as I use to, but I'm encouraged by the fact that the Esperion team has stuck together. It's easy to hide behind a screen and take cheap shots at people on CP. And knowing the sole individual who keeps ranting about the same few topics at a feverish pitch: stock price, scientific discussion, lay-offs, sales performance, clamoring, interview process, conference calls (that he's not privy to), etc. We've identified the individual posting. Know that our screening process was very accurate in choosing the best candidates. While true that there may have been other candidates with relationships, often times we've find those are exaggerated. The tenured reps we have are solid with business relationships. Many of the interviewing tenured individuals weren't that hungry. We might have opted for a younger worker who would put in more effort who would develop the relationships.
And, its worked. Very well. The sour individual who posts knows nothing about our sales performance or the inner workings of Esperion. We have a bright future. Feel proud working with the lipid company. Make no mistake about it-providers know who we are. So do payers. Thats why our access is improving. Even in the midst of a very difficult period. We can and do have excellent interactions-on a science level-with those we speak to. We don't need to conduct those points with someone who is so bitter that it has fully consumed them. He can't let it go. As he continues to post, we'll just go on our way to hitting our sales goals. Hopefully he finds gainful employment in a job thats more fulfilling. For the record, his interview was not strong at all. He didnt' come close to being as prepared as some with a lot less tenure who really wanted to work for the lipid experts.
Continue to win Esperion! The future is bright!
CB
And, its worked. Very well. The sour individual who posts knows nothing about our sales performance or the inner workings of Esperion. We have a bright future. Feel proud working with the lipid company. Make no mistake about it-providers know who we are. So do payers. Thats why our access is improving. Even in the midst of a very difficult period. We can and do have excellent interactions-on a science level-with those we speak to. We don't need to conduct those points with someone who is so bitter that it has fully consumed them. He can't let it go. As he continues to post, we'll just go on our way to hitting our sales goals. Hopefully he finds gainful employment in a job thats more fulfilling. For the record, his interview was not strong at all. He didnt' come close to being as prepared as some with a lot less tenure who really wanted to work for the lipid experts.
Continue to win Esperion! The future is bright!
CB
anonymous
Guest
anonymous
Guest
Thank you. So tired of his rants and hang-ups
anonymous
Guest
anonymous
Guest
anonymous
Guest
Team Esperion-thanks for your diligence the past little while as we navigate through a difficult period. I'm extremely pleased with the effort the team has put forth. Yes, clinics are closed for the time being. But, they will reopen. I hear of the discussion about me and the company on CP. I don't routinely follow as often as I use to, but I'm encouraged by the fact that the Esperion team has stuck together. It's easy to hide behind a screen and take cheap shots at people on CP. And knowing the sole individual who keeps ranting about the same few topics at a feverish pitch: stock price, scientific discussion, lay-offs, sales performance, clamoring, interview process, conference calls (that he's not privy to), etc. We've identified the individual posting. Know that our screening process was very accurate in choosing the best candidates. While true that there may have been other candidates with relationships, often times we've find those are exaggerated. The tenured reps we have are solid with business relationships. Many of the interviewing tenured individuals weren't that hungry. We might have opted for a younger worker who would put in more effort who would develop the relationships.
And, its worked. Very well. The sour individual who posts knows nothing about our sales performance or the inner workings of Esperion. We have a bright future. Feel proud working with the lipid company. Make no mistake about it-providers know who we are. So do payers. Thats why our access is improving. Even in the midst of a very difficult period. We can and do have excellent interactions-on a science level-with those we speak to. We don't need to conduct those points with someone who is so bitter that it has fully consumed them. He can't let it go. As he continues to post, we'll just go on our way to hitting our sales goals. Hopefully he finds gainful employment in a job thats more fulfilling. For the record, his interview was not strong at all. He didnt' come close to being as prepared as some with a lot less tenure who really wanted to work for the lipid experts.
Continue to win Esperion! The future is bright!
CB
Bring on the marching band.
anonymous
Guest
anonymous
Guest
Well well well CB. Nice to see you climb out from under the rock or should we say the buffet tables that have recently opened back up. The lists of things you mentioned have all been your talking points since January. Scientific process, clamoring were all your doing . Don't come on here like your Mr. Brady from the Brady Bunch like your some Pharma Godfather. You've no idea who this is. I didn't interview with you. You said in an earlier post you had a rat on your team. So which is it ?? You admit you took reps with less relationshipd and poor performance track records because you said they were hungrier. Well they should be hungrier because they sucked at their last job and their starving for groceries. Your managed care has been weak. You've no momentum. We know you monitor this site daily. Countless times employees have been on here telling you to stop because your embarassing the company and them. In some posts you claim great access now today you say Esperion has closed offices. Which is it??What your really trying to say is this thats there's been no clamoring, no fielding phone calls from doctors nonstop.Just look at Esperions first quarter results. Does it look impressive? What is your team of champions been doing for 4 months. When is managemen going to wise up to the reps slacking? What about you?? How can you possibly be filling a day? Uber takeout is my guess. Hopefully with your endless free time you bought some new suits . Maybe something that hides the ever expanding mid section. A good double breasted suit would work better for you. Your the one who has to sleep with those pathetic scripts numbers your team and the company has generated. Good luck with those sales goals. You got what you paid for in those cattle call information stealing interviews. Word is out on Esperion.Team Esperion-thanks for your diligence the past little while as we navigate through a difficult period. I'm extremely pleased with the effort the team has put forth. Yes, clinics are closed for the time being. But, they will reopen. I hear of the discussion about me and the company on CP. I don't routinely follow as often as I use to, but I'm encouraged by the fact that the Esperion team has stuck together. It's easy to hide behind a screen and take cheap shots at people on CP. And knowing the sole individual who keeps ranting about the same few topics at a feverish pitch: stock price, scientific discussion, lay-offs, sales performance, clamoring, interview process, conference calls (that he's not privy to), etc. We've identified the individual posting. Know that our screening process was very accurate in choosing the best candidates. While true that there may have been other candidates with relationships, often times we've find those are exaggerated. The tenured reps we have are solid with business relationships. Many of the interviewing tenured individuals weren't that hungry. We might have opted for a younger worker who would put in more effort who would develop the relationships.
And, its worked. Very well. The sour individual who posts knows nothing about our sales performance or the inner workings of Esperion. We have a bright future. Feel proud working with the lipid company. Make no mistake about it-providers know who we are. So do payers. Thats why our access is improving. Even in the midst of a very difficult period. We can and do have excellent interactions-on a science level-with those we speak to. We don't need to conduct those points with someone who is so bitter that it has fully consumed them. He can't let it go. As he continues to post, we'll just go on our way to hitting our sales goals. Hopefully he finds gainful employment in a job thats more fulfilling. For the record, his interview was not strong at all. He didnt' come close to being as prepared as some with a lot less tenure who really wanted to work for the lipid experts.
Continue to win Esperion! The future is bright!
CB
anonymous
Guest
anonymous
Guest
Team Esperion-thanks for your diligence the past little while as we navigate through a difficult period. I'm extremely pleased with the effort the team has put forth. Yes, clinics are closed for the time being. But, they will reopen. I hear of the discussion about me and the company on CP. I don't routinely follow as often as I use to, but I'm encouraged by the fact that the Esperion team has stuck together. It's easy to hide behind a screen and take cheap shots at people on CP. And knowing the sole individual who keeps ranting about the same few topics at a feverish pitch: stock price, scientific discussion, lay-offs, sales performance, clamoring, interview process, conference calls (that he's not privy to), etc. We've identified the individual posting. Know that our screening process was very accurate in choosing the best candidates. While true that there may have been other candidates with relationships, often times we've find those are exaggerated. The tenured reps we have are solid with business relationships. Many of the interviewing tenured individuals weren't that hungry. We might have opted for a younger worker who would put in more effort who would develop the relationships.
And, its worked. Very well. The sour individual who posts knows nothing about our sales performance or the inner workings of Esperion. We have a bright future. Feel proud working with the lipid company. Make no mistake about it-providers know who we are. So do payers. Thats why our access is improving. Even in the midst of a very difficult period. We can and do have excellent interactions-on a science level-with those we speak to. We don't need to conduct those points with someone who is so bitter that it has fully consumed them. He can't let it go. As he continues to post, we'll just go on our way to hitting our sales goals. Hopefully he finds gainful employment in a job thats more fulfilling. For the record, his interview was not strong at all. He didnt' come close to being as prepared as some with a lot less tenure who really wanted to work for the lipid experts.
Continue to win Esperion! The future is bright!
CB
Morale must be very low, if CB has to come on CP to give a pep talk.
Zoom and phone conferencing must not be convincing to the Scientifically Hired Lipid Experts.
Hmmmm
anonymous
Guest
anonymous
Guest
Morale must be very low, if CB has to come on CP to give a pep talk.
Zoom and phone conferencing must not be convincing to the Scientifically Hired Lipid Experts.
Hmmmm
Has anybody in their career ever heard of a RD or VP for that matter come onto Cafepharma to give his team a pep talk?Are we supposed to be impressed by this? Doesn't this sound kinda desperate and pathetic? I can't recall ever seeing this done before . Maybe they should find out what their reps are doing everyday. Does this sound like a company anyone would want to work for?
anonymous
Guest
anonymous
Guest
You applied. You didn’t get hired. You have nothing to do but post the same shit over and over and over. You are obnoxious. So glad you aren’t part of the family.Has anybody in their career ever heard of a RD or VP for that matter come onto Cafepharma to give his team a pep talk?Are we supposed to be impressed by this? Doesn't this sound kinda desperate and pathetic? I can't recall ever seeing this done before . Maybe they should find out what their reps are doing everyday. Does this sound like a company anyone would want to work for?
anonymous
Guest
anonymous
Guest
You applied. You didn’t get hired. You have nothing to do but post the same shit over and over and over. You are obnoxious. So glad you aren’t part of the family.
Never interviewed here. Sorry you have the wrong person. Who would want to be apart of this inbred family of human debris. This is the minor leagues. Your reps aren't working much. Get a handle on this before you hit the iceberg. Try to figure out a way to sell this novel generic.
anonymous
Guest
anonymous
Guest
You are a liar; You lied in the interview and you didn’t get hired. And by the way as you continue on your scientific rant, there is no generic for our drug, it’s a unique and novel MOA brought to the medical community by the lipids experts, of which you are not a member. Loser.Never interviewed here. Sorry you have the wrong person. Who would want to be apart of this inbred family of human debris. This is the minor leagues. Your reps aren't working much. Get a handle on this before you hit the iceberg. Try to figure out a way to sell this novel generic.
anonymous
Guest
anonymous
Guest
You are a liar; You lied in the interview and you didn’t get hired. And by the way as you continue on your scientific rant, there is no generic for our drug, it’s a unique and novel MOA brought to the medical community by the lipids experts, of which you are not a member. Loser.
Sorry CB- I don't know you or interviewed with you or anyone in your outhouse of a company. And BA is a novel generic because that's what it's similar too. Identical reductions and is a Zetia at best. 300.00 per month also for generic knockoff. You should know this as you claim your a lipid expert from the Scientific hires. Just keep up with your clamoring as we need a good laugh a few times a day watching you squirm when your numbers come in. You guys act like your in some secret society of lipid Experts. Do you have secret passwords and decoder rings also?? Maybe burn incense and candles and wear back hoods over your heads chanting "stupid is as stupid does""
anonymous
Guest
anonymous
Guest
Another cut a paste from Over. Quite a life for you to be up at 130am playing keyboard putz. You for sure were molested by a family member. How was it getting back doored by Uncle Jake at the sleepover in the tent?
anonymous
Guest
anonymous
Guest
Another cut a paste from Over. Quite a life for you to be up at 130am playing keyboard putz. You for sure were molested by a family member. How was it getting back doored by Uncle Jake at the sleepover in the tent?
hey shit ass TTPW….how many trips have you "one" in your career? Stupid shit
anonymous
Guest
anonymous
Guest
How my reps have quit since the hiring date in February.
I know of a few that have left which is surprising since they are collecting a paycheck for sitting home, and the starting pay is very good.
I know of a few that have left which is surprising since they are collecting a paycheck for sitting home, and the starting pay is very good.
anonymous
Guest
anonymous
Guest
Wow, nice week for NRx. Expertise = $ales! It’s always great to see the numbers grow! Accounts are opening up and improved access should help spur additional growth. Being involved In a great launch is memorable and a real career booster!
anonymous
Guest
anonymous
Guest
How my reps have quit since the hiring date in February.
I know of a few that have left which is surprising since they are collecting a paycheck for sitting home, and the starting pay is very good.
A bunch - boredom, no pressure , sick of doing Tic Tock and Candy Crusher . Milked Esperion for 4 month vacation.
anonymous
Guest
anonymous
Guest
Wow, nice week for NRx. Expertise = $ales! It’s always great to see the numbers grow! Accounts are opening up and improved access should help spur additional growth. Being involved In a great launch is memorable and a real career booster!
Thanks CB for checking in. The numbers are dismal. No the offices aren't opening backup. Patients first get priority in coming in and offices have 4 months backlog to see them. Their not interested in a generic Zetia with no outcomes. Their laughing at you.
anonymous
Guest
anonymous
Guest
Wow, nice week for NRx. Expertise = $ales! It’s always great to see the numbers grow! Accounts are opening up and improved access should help spur additional growth. Being involved In a great launch is memorable and a real career booster!
Open up.
We will see the facade that is the Scientifically hired now Lipid trained Experts.
Bring it on !
anonymous
Guest
anonymous
Guest
Thanks CB for checking in. The numbers are dismal. No the offices aren't opening backup. Patients first get priority in coming in and offices have 4 months backlog to see them. Their not interested in a generic Zetia with no outcomes. Their laughing at you.
The pressure for scripts builds.
CB are you ready with the PIP's to motivate the Lipid Experts ?